Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Wilms Tumor 1Sarcoma 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia 1Kidney Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

fludarabine phosphate 4Filgrastim 4Cyclophosphamide 4Antilymphocyte Serum 4Mycophenolic Acid 3Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Methotrexate 2Cyclosporine 2Counseling 2Busulfan 2Bupropion 2thymoglobulin 1temsirolimus 1tanespimycin 1sargramostim 1pembrolizumab 1liposomal doxorubicin 1ixabepilone 1glutamic acid diethyl ester 1fludarabine 1cc-486 1carboxyamido-triazole 1aldesleukin 1Zinc Oxide 1Whole-Body Irradiation 1Voriconazole 1Varenicline 1Traumeel S 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Glutamic Acid × Other hematologic neoplasm × Clear all
NCT00369564 2021-08-11

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

University of South Florida

Phase 3 Completed
250 enrolled 10 charts
GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡